People: Consort Medical PLC (CSRT.L)

CSRT.L on London Stock Exchange

900.00GBp
11:35am EDT
Price Change (% chg)

0.00p (+0.00%)
Prev Close
900.00p
Open
900.00p
Day's High
907.00p
Day's Low
896.00p
Volume
129,209
Avg. Vol
43,258
52-wk High
1,113.00p
52-wk Low
733.00p

Search Stocks

Summary

Name Age Since Current Position

Peter Fellner

71 2009 Non-Executive Independent Chairman of the Board

Jonathan Glenn

43 2007 Chief Executive, Executive Director

Richard Cotton

2012 Group Finance Director, Executive Director

John Slater

2009 General Counsel, Company Secretary

Nick Higgins

55 2011 Corporate Development Director, Executive Director

Steve Crummett

2012 Non-Executive Director

Ian Nicholson

2012 Non-Executive Director

Lynn Drummond

53 2011 Non-Executive Independent Director

William Jenkins

64 2011 Senior Non-Executive Independent Director

Biographies

Name Description

Peter Fellner

Dr. Peter Fellner is Non-Executive Independent Chairman of the Board of Consort Medical Plc., since May 2009. He served as a director since November 2005. He is also Chairman of Vernalis plc, Optos plc, Biotie Therapies Corp. and Vice Chairman of Astex Pharmaceuticals, Inc. In addition he serves as a director of the global biopharmaceutical company UCB SA. He is a member of the Novo A/S Advisory Group. Dr Fellner previously served as Chairman of Celltech Group plc from 2003 to July 2004, having been CEO from 1990 onwards. Before joining Celltech he was CEO of Roche UK from 1986 to 1990. More recently he served as Chairman of Acambis plc from 2006 until its acquisition by Sanofi Aventis in 2008, and of Premier Research Group plc from 2007 to 2008, when it was acquired by a private-equity backed group.

Jonathan Glenn

Mr. Jonathan M. Glenn is Chief Executive, Executive Director of Consort Medical plc. He was appointed Chief Executive in December 2007 and before that had been Group Finance Director since September 2006. Prior to joining Consort Medical plc, Jonathan was global Head of Finance at Celltech Group plc and later Chief Financial Officer of Akubio Ltd, a Cambridge-based developer of instrumentation for the life sciences industry. He is a member of the Institute of Chartered Accountants in England and Wales.

Richard Cotton

Mr. Richard Cotton has been appointed as Group Finance Director, Executive Director of Consort Medical Plc., with effect from 25th June 2012. Mr. Cotton, a Chartered Management Accountant, has been appointed Group Finance Director of Consort Medical with effect from 25 June 2012. From 2008 to 2011 he was Group Finance Director of Vitec Group plc, from 2005 to 2008 Group Finance Director at Wagon plc (Wagon plc entered administration on 10th December 2008), and from 2001 to 2005 Group Finance Director of McLeod Russell plc.

John Slater

Nick Higgins

Mr. Nick Higgins is Corporate Development Director, Executive Director of Consort Medical plc., since 1 January 2011. He having joined the Company in January 2010. Nick has spent over 25 years in the healthcare industry focusing on business and corporate development. He joined the Company from Intercytex Group plc where he was Chief Executive for five years. Prior to that he was Chief Business Officer of Acambis plc, a vaccines specialist, for 11 years. Before Acambis he worked for Porton Developments, the PA Consulting Group and Unilever.

Steve Crummett

Mr. Steve Crummett has been appointed as Non-Executive Director of Consort Medical PLC., with effect from 13 June 2012. is Group Finance Director of Filtrona plc, a FTSE 250 company, having been appointed to the role in 2008. Filtrona is a international supplier of speciality plastic, fibre and foam products. From 2003 to 2006, Steve was Group Director, Mergers & Acquisitions of the FTSE 100 company Exel plc. Steve qualified as a Chartered Accountant with Arthur Andersen. He has also been appointed as Chair the Audit Committee, and member of the Nomination Committee effective 30 August 2012.

Ian Nicholson

Mr. Ian Nicholson has been appointed as Non-Executive Director of Consort Medical PLC., with effect from 13 June 2012. He has been Chief Executive of Chroma Therapeutics Limited, a drug discovery and development company since 2004. He is Chairman of Bioventix Ltd, a diagnostics company, and a Non-executive Director of Symphogen A/S, an antibody therapeutics company. From 2000 to 2004 Ian was Senior Vice President, Business Development at Celltech Group plc, then the UK's biotechnology company. He has experience in licensing, mergers and acquisitions, and market development in the UK, Europe and the US. He has also been appointed as the member of Nomination Committee.

Lynn Drummond

Dr. Lynn Drummond is Non-Executive Independent Director of Consort Medical plc., since 9 February 2011. Dr. Drummond is a Fellow of the Royal Society of Edinburgh and the Royal Society of Chemistry and is currently a non-executive director of Alimentary Health Limited, a biotechnology company specialising in commercialising probiotics for medical use, based in Cork, Ireland. She was previously a Managing Director at Rothschild and her focus was on advising clients within the healthcare sector.

William Jenkins

Dr. William J. Jenkins, M.D., has been appointed as Senior Non-Executive Independent Director of Consort Medical plc with effect from 1 September 2011. He was appointed as a non-executive director in May 2009 and is Principal of William Jenkins Pharma Consulting. He has been advising a wide range of pharma and biotech companies and investment and venture capital firms in the healthcare sector since 1999. Formerly head of Worldwide Clinical and Regulatory Affairs for Novartis Pharma AG and held similar positions with Ciba Geigy AG and Glaxo. He is also a member of the Scientific Advisory Boards of Piramal Life Sciences; BB Biotech Ventures and Evotec AG.

Basic Compensation

Name Fiscal Year Total

Peter Fellner

120,000

Jonathan Glenn

848,000

Richard Cotton

--

John Slater

--

Nick Higgins

435,000

Steve Crummett

--

Ian Nicholson

--

Lynn Drummond

--

William Jenkins

--
As Of 29 Apr 2012

Options Compensation

Search Stocks